Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984;17(Suppl 1):108S–111S. doi: 10.1111/j.1365-2125.1984.tb02442.x

The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients

A Salvetti, R Pedrinelli, P Alberici, A Magagna, B Abdel-Haq
PMCID: PMC1463273  PMID: 6378233

Abstract

Indomethacin and sulindac were used as tools to study the role of renal and/or systemic prostaglandins in the pharmacological response to atenolol. Patients receiving chronic treatment with atenolol 100 mg received indomethacin 50 mg twice daily or sulindac 200 mg twice daily in a randomised crossover trial. Indomethacin significantly reduced the antihypertensive action of atenolol while sulindac had no effect. The role that systemic and/or renal prostaglandins may play in the antihypertensive action of atenolol is discussed with reference to renal PGI2 production and inhibition of platelet cyclo-oxygenase.

Keywords: atenolol, indomethacin, pharmacodynamics, prostaglandins, sulindac

Full text

PDF
108S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Durão V., Rico J. M. Modification by indomethacin of the blood pressure lowering effect of pindolol and propranolol in conscious rabbits. Eur J Pharmacol. 1977 Jun 15;43(4):377–381. doi: 10.1016/0014-2999(77)90044-9. [DOI] [PubMed] [Google Scholar]
  2. Lopez-Ovejero J. A., Weber M. A., Drayer J. I., Sealey J. E., Laragh J. H. Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension. Clin Sci Mol Med Suppl. 1978 Dec;4:203s–205s. doi: 10.1042/cs055203s. [DOI] [PubMed] [Google Scholar]
  3. Patrono C., Ciabattoni G., Pugliese F., Pinca E., Castrucci G., De Salvo A., Satta M. A., Parachini M. Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function. Adv Prostaglandin Thromboxane Res. 1980;6:187–191. [PubMed] [Google Scholar]
  4. Patrono C., Pugliese F., Ciabattoni G., Patrignani P., Maseri A., Chierchia S., Peskar B. A., Cinotti G. A., Simonetti B. M., Pierucci A. Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest. 1982 Jan;69(1):231–239. doi: 10.1172/JCI110435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Salvetti A., Arzilli F., Pedrinelli R., Beggi P., Motolese M. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients. Eur J Clin Pharmacol. 1982;22(3):197–201. doi: 10.1007/BF00545214. [DOI] [PubMed] [Google Scholar]
  6. Zucchelli G. C., Malvano R., Rosa U., Salvetti A. Control of the enzyme systems in plasma renin activity measurement by angiotensin I radioimmunoassay. J Nucl Biol Med. 1973 Oct-Dec;17(4):187–195. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES